# Escope

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/escope

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Website: www.escopetech.com
- Total disclosed funding: $16M
- Latest round: Series A (Nov 26, 2021)
- Investors on record: 4

## About

Based in Shenzhen, China and established in 2017, Escope operates as a healthcare IT (information technology) company that focuses on diagnosis of coronary heart disease. The company cooperates with many hospitals such as Huashan Hospital, Fudan University, Fuwai Hospital, CAMS & PUMC and Peking University Third Hospital.

The company provides a global professional imaging and data analysis platform for cardiovascular and cerebrovascular diseases. The company also provides solutions for screening, diagnosis, preoperative planning, intraoperative navigation to postoperative follow-up. The company's product covers many fields such as coronary (coronary artery analysis), cardiac (heart disease function evaluation) and cranial (intracranial artery analysis). The product of the company includes CAscope, XAscope, HCscope and ICAscope. The company adopts artificial intelligence, imaging and machine vision technology.

The company will increase investment in researching and developing product and promote clinical trial landing.

## Funding rounds

- Series A, Nov 26, 2021, $16M — Centurium Cap, Tasly Holding Group, Shengwei Rongquan Capital, Shanda Capital

## Investors

- Centurium Cap — Series A
- Tasly Holding Group — Series A
- Shengwei Rongquan Capital — Series A
- Shanda Capital — Series A